Articles

Kasuwancin Jiyya na Osteogenesis Osteogenesis na Duniya, ta Magunguna ta Hanyar Gudanarwa da ta Yanki: Girman, Raba, Hanyoyi da Binciken Dama, 2023 - 2030

Osteogenesis imperfecta cuta ce ta kwayoyin halitta wacce ke shafar kasusuwa kuma tana hana jiki gina kasusuwa masu karfi.

Wannan cuta tana sa kashi ya karye kuma yana karyewa cikin sauki ba tare da wani dalili ba.

Osteogenesis Imperfecta ana kiransa da samuwar kashi mara kyau kuma mutanen da ke fama da wannan cuta suna da kasusuwa da ke karaya ko karya cikin sauki.

Introduzione

Osteogenesis imperfecta an fi saninsa da cutar kasusuwa. A cikin lokuta masu tsanani, karaya da yawa kan zama ruwan dare, yayin da mai rauni yakan haifar da wasu karaya ko karyewar kashi a rayuwar mutum. An haifi mutanen da ke da wannan yanayin ba za su iya samar da nama mai haɗi ba ko kuma suna da shi saboda kuskuren kwayoyin halitta. Yana da tasiri a kan kira na collagen, furotin mai haɗin gwiwa wanda ke ƙarfafa kasusuwa. Cutar tana faruwa a cikin nau'i na I da IX, tare da ni mai laushi da IX mai mutuwa. Babban alamar osteogenesis imperfecta shine karaya akai-akai. Sauran alamomin sun hada da sako-sako da haɗin gwiwa, gurɓataccen ƙasusuwa, asarar ji, matsalolin numfashi da matsalolin haƙori. Ana iya tabbatar da imperfecta osteogenesis ta hanyar DNA ko gwajin collagen.

jiyya

Babu magani ga wannan saboda yanayin kwayoyin halitta ne. Motsa jiki da daina shan taba misalai biyu ne na zaɓin salon rayuwa mai kyau waɗanda zasu iya taimakawa hana karaya. Ƙunƙarar takalmin gyaran kafa, magungunan kashe radadi, da kuma kula da karayar kashi duk suna da taimako. Ana iya amfani da maganin rigakafi da maganin kashe kwayoyin cuta don magance cututtukan kashi. Haɓaka buƙatun sabbin hanyoyin kwantar da hankali don kula da osteogenesis imperfecta da yarjejeniyar lasisi da dabarun haɗin gwiwa daga manyan playersan wasan masana'antu don haɓaka jiyya ana tsammanin za su haifar da haɓakar jiyya ta duniya na kasuwar osteogenesis imperfecta a cikin lokacin hasashen.

Halin kasuwa

Haɓaka tallafin R&D don haɓaka sabbin jiyya da hanyoyin kwantar da hankali shine babban abin da ke haifar da haɓakar kasuwar jiyya ta osteogenesis imperfecta. Haka kuma, yarjejeniyoyin ba da izini da dabarun haɗin gwiwar manyan 'yan wasan masana'antu don haɓaka jiyya na OI wani lamari ne da ke haifar da haɓakar kasuwa. Bugu da ƙari, osteogenesis imperfecta cuta ce ta kwayoyin halitta kuma tarihin iyali na mutanen da ke da OI yana haifar da karuwar adadin lokuta a duk duniya, wanda ake tsammanin zai haifar da haɓakar kasuwa.

Misali, a cikin Mayu 2021, Mereo BioPharma Group plc ya ba da sanarwar ƙarfafa bayanan watanni 6 daga nazarin asibiti na Phase II-B a cikin manya marasa lafiya tare da osteogenesis imperfecta nau'in IV, III ko kuma na ji da setursumab (BPS-804). Hukumar Kula da Magunguna ta Turai (EMA) ta amince da tsarin binciken lafiyar yara na kamfanin na BPS-804 da ƙirar nazarin rajista, kuma ɗan takarar magani yanzu ya shirya don Mataki na III don yawan yaran yara.

Babban fasali na binciken:

Wannan rahoton yana ba da zurfin bincike game da kasuwar Jiyya ta Osteogenesis Imperfecta ta duniya kuma tana ba da girman kasuwa (USD Million) da ƙimar haɓakar shekara-shekara (CAGR%) don lokacin hasashen (2023-2030), la'akari da 2022 a matsayin farkon shekara.
Yana fayyace yuwuwar damar samun kudin shiga a sassa daban-daban kuma yana bayyana kyawawan tsararrun shawarwarin saka hannun jari na wannan kasuwa.
Hakanan wannan binciken yana ba da mahimman bayanai game da direbobin kasuwa, ƙuntatawa, dama, sabbin samfura ko amincewa, yanayin kasuwa, hangen nesa na yanki, da dabarun gasa da manyan 'yan wasa suka ɗauka.
Bayanan martaba manyan 'yan wasa a cikin kasuwar Jiyya na Osteogenesis Imperfecta na duniya dangane da ma'auni masu zuwa: manyan abubuwan kamfani, fayil ɗin samfur, mahimman bayanai, aikin kuɗi da dabaru.
Manyan kamfanonin da aka rufe cikin iyakokin wannan binciken sune BioSenic SA, Mereo Biopharma Group PLC, CELGENE CORPORATION, Eli Lilly da Kamfanin, Cipla Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd. , Merck & Co., Inc., Jubilant Pharmova Limited, Aurobindo Pharma, Quince, Ultragenyx Pharmaceutical Inc. da OrthoPediatrics Corp.
Bayanin da aka samu daga wannan rahoto zai baiwa masu kasuwa da hukumomin gudanarwa na kamfanoni damar yanke shawara game da ƙaddamar da samfuran su nan gaba, nau'in haɓakawa, faɗaɗa kasuwa da dabarun talla.

Rahoton Kasuwar Magani na Osteogenesis Imperfecta na Duniya ya yi niyya ga masu ruwa da tsaki a cikin wannan masana'antar, gami da masu saka hannun jari, masu siyarwa, masu kera samfura, masu rarrabawa, sabbin masu shiga, da manazarta kudi:

Masu ruwa da tsaki za su sauƙaƙe yanke shawara ta hanyar dabaru daban-daban da aka yi amfani da su wajen nazarin kasuwar Maganin Osteogenesis Imperfecta na duniya.